ROMEDLACNOR6
ROMEDLACNOR6
Med Life SA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 5.88B EUR | 6.3B EUR | 6.23B EUR |
Enterprise Value | 7.81B EUR | 8.21B EUR | 8.08B EUR |
Valuation Multiples | |||
Trailing P/E | 1,108x | -- | 430.81x |
Forward P/E | 221.6x | -- | -- |
Price to Sales | 1.76x | 1.89x | 1.94x |
Price to Book | 12.85x | 13.76x | 12.6x |
EV/Revenue | 2.34x | 2.47x | 2.51x |
EV/EBITDA | 21.68x | 21.61x | 19.19x |
Price to FCF (P/FCF) | 63.83x | 280.33x | 182.27x |
EV/FCF | 84.81x | 365.54x | 236.4x |
FCF Yield | 1.57% | 0.36% | 0.55% |